Bases Neurobiológicas y Psicológicas de los Trastornos Mentales. Trastornos del Neurodesarrollo

Solmi, M; Croatto, G; Piva, G; Rosson, S; Fusar-Poli, P; Rubio, JM; Carvalho, AF; Vieta, E; Arango, C; DeTore, NR; Eberlin, ES; Mueser, KT; Correll, CU.

Efficacy and acceptability of psychosocial interventions in schizophrenia: systematic overview and quality appraisal of the meta-analytic evidence

MOLECULAR PSYCHIATRY. 2023; 28(1): 354-368 Nº de citas: 64 [doi:10.1038/s41380-022-01727-z]

Fernandez-Pena, A; de Blas, DM; Navas-Sanchez, FJ; Marcos-Vidal, L; Gordaliza, PM; Santonja, J; Janssen, J; Carmona, S; Desco, M; Aleman-Gomez, Y.

ABLE: Automated Brain Lines Extraction Based on Laplacian Surface Collapse

NEUROINFORMATICS. 2023; 21(1): 145-162 Nº de citas: 1 [doi:10.1007/s12021-022-09601-7]

de las Cuevas, C; Gutierrez-Rojas, L; Alvarez-Mon, MA; Andreu-Bernabeu, A; Capitan, L; Gomez, JC; Grande, I; Hidalgo-Mazzei, D; Mateos, R; Moreno-Gea, P; De Vicente-Munoz, T; Ferre, F.

Evaluating the Effect of a Telepsychiatry Educational Program on the Awareness, Knowledge, Attitude, and Skills of Telepsychiatry Among Spanish Psychiatrists during COVID-19 Pandemic

TELEMEDICINE AND E-HEALTH. 2023; 29(1): 102-108 Nº de citas: 6 [doi:10.1089/tmj.2022.0051]

Garcia-Alcon, A; Gonzalez-Penas, J; Weckx, E; Penzol, MJ; Gurriaran, X; Costas, J; Diaz-Caneja, CM; Moreno, C; Hernandez, P; Arango, C; Parellada, M.

Oxytocin Exposure in Labor and its Relationship with Cognitive Impairment and the Genetic Architecture of Autism

JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS. 2023; 53(1): 66-79 Nº de citas: 3 [doi:10.1007/s10803-021-05409-7]

Elvira UKA; Seoane, S; Janssen, J; Janssen, N.

Contributions of human amygdala nuclei to resting-state networks

PLoS One. 2022; 17(12): Nº de citas: 5 [doi:10.1371/journal.pone.0278962]

de Haan, L; van Tricht, M; van Dijk, F; Arango, C; Diaz-Caneja, CM; Bobes, J; Garcia-Alvarez, L; Leucht, S.

Optimizing subjective wellbeing with amisulpride in first episode schizophrenia or related disorders

PSYCHOLOGICAL MEDICINE. 2022; 53(13): 1-6 Nº de citas: 1 [doi:10.1017/S0033291722003142]

Constantinides C; Han LKM; Alloza C; Antonucci LA; Arango C; Ayesa-Arriola R; Banaj N; Bertolino A; Borgwardt S; Bruggemann J; Bustillo J; Bykhovski O; Calhoun V; Carr V; Catts S; Chung YC; Crespo-Facorro B; Díaz-Caneja CM; Donohoe G; Plessis SD; Edmond J; Ehrlich S; Emsley R; Eyler LT; Fuentes-Claramonte P; Georgiadis F; Green M; Guerrero-Pedraza A; Ha M; Hahn T; Henskens FA; Holleran L; Homan S; Homan P; Jahanshad N; Janssen J; Ji E; Kaiser S; Kaleda V; Kim M; Kim WS; Kirschner M; Kochunov P; Kwak YB; Kwon JS; Lebedeva I; Liu J; Mitchie P; Michielse S; Mothersill D; Mowry B; de la Foz VO; Pantelis C; Pergola G; Piras F; Pomarol-Clotet E; Preda A; Quidé Y; Rasser PE; Rootes-Murdy K; Salvador R; Sangiuliano M; Sarró S; Schall U; Schmidt A; Scott RJ; Selvaggi P; Sim K; Skoch A; Spalletta G; Spaniel F; Thomopoulos SI; Tomecek D; Tomyshev AS; Tordesillas-Gutiérrez D; van Amelsvoort T; Vázquez-Bourgon J; Vecchio D; Voineskos A; Weickert CS; Weickert T; Thompson PM; Schmaal L; van Erp TGM; Turner J; Cole JH; Dima D; Walton E.

Brain ageing in schizophrenia: evidence from 26 international cohorts via the ENIGMA Schizophrenia consortium

MOLECULAR PSYCHIATRY. 2022; 28(3): 1201-1209 Nº de citas: 65 [doi:10.1038/s41380-022-01897-w]

Garcia-Rizo, C; Cabrera, B; Bioque, M; Mezquida, G; Lobo, A; Gonzalez-Pinto, A; Diaz-Caneja, CM; Corripio, I; Vieta, E; Baeza, I; Garcia-Portilla, MP; Gutierrez-Fraile, M; Rodriguez-Jimenez, R; Garriga, M; Fernandez-Egea, E; Bernardo, M; PEPs GROUP.

The effect of early life events on glucose levels in first-episode psychosis

Frontiers in Endocrinology. 2022; 13: Nº de citas: 8 [doi:10.3389/fendo.2022.983792]

Arango, C; Fusar-Poli, P.

Primary prevention in psychiatry is not science fiction

EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2022; 65: 30-32 Nº de citas: 5 [doi:10.1016/j.euroneuro.2022.09.008]

Vita-Barrull, N; March-Llanes, J; Guzman, N; Estrada-Plana, V; Mayoral, M; Moya-Higueras, J.

The Cognitive Processes Behind Commercialized Board Games for Intervening in Mental Health and Education: A Committee of Experts

Games for Health Journal. 2022; 11(6): 414-424 Nº de citas: 7 [doi:10.1089/g4h.2022.0109]

Smits, A; Annaert, P; Cavallaro, G; De Cock, PAJG; de Wildt, SN; Kindblom, JM; Lagler, FB; Moreno, C; Pokorna, P; Schreuder, MF; Standing, JF; Turner, MA; Vitiello, B; Zhao, W; Weingberg, AM; Willmann, R; van den Anker, J; Allegaert, K.

Current knowledge, challenges and innovations in developmental pharmacology: A combined conect4children Expert Group and European Society for Developmental, Perinatal and Paediatric Pharmacology White Paper

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2022; 88(12): 4965-4984 Nº de citas: 34 [doi:10.1111/bcp.14958]

Bioque, M; Matias-Martins, AC; Llorca-Bofi, V; Mezquida, G; Cuesta, MJ; Vieta, E; Amoretti, S; Lobo, A; Gonzalez-Pinto, A; Moreno, C; Roldan, A; Martinez-Aran, A; Baeza, I; Berge, D; Garcia-Rizo, C; Herrero, SM; Bernardo, M.

Neutrophil to Lymphocyte Ratio in Patients With a First Episode of Psychosis: A Two-Year Longitudinal Follow-up Study

SCHIZOPHRENIA BULLETIN. 2022; 48(6): 1327-1335 Nº de citas: 39 [doi:10.1093/schbul/sbac089]

Solanes, A; Mezquida, G; Janssen, J; Amoretti, S; Lobo, A; Gonzalez-Pinto, A; Arango, C; Vieta, E; Castro-Fornieles, J; Berge, D; Albacete, A; Gine, E; Parellada, M; Bernardo, M; Pomarol-Clotet, E; Radua, J.

Combining MRI and clinical data to detect high relapse risk after the first episode of psychosis

Schizophrenia. 2022; 8(1): Nº de citas: 5 [doi:10.1038/s41537-022-00309-w]

Braak, S; Su, T; Krudop, W; Pijnenburg, YAL; Reus, LM; van der Wee, N; Bilderbeck, AC; Dawson, GR; Winter-van Rossum, I; Campos, AV; Arango, C; Saris, IMJ; Kas, MJ; Penninx, BWJH.

Theory of Mind and social functioning among neuropsychiatric disorders: A transdiagnostic study

EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2022; 64: 1-11 Nº de citas: 6 [doi:10.1016/j.euroneuro.2022.08.005]

Garcia-Lopez, M; Alonso-Sanchez, M; Leal, I; Martin-Hernandez, D; Caso, JR; Diaz-Caneja, CM; Andreu-Bernabeu, A; Arango, C; Rodriguez-Jimenez, R; Sanchez-Pastor, L; Diaz-Marsa, M; Mellor-Marsa, B; Ibanez, A; Malpica, N; Bravo-Ortiz, MF; Baca-Garcia, E; Ayuso-Mateos, JL; Izquierdo, A.

The relationship between negative symptoms, social cognition, and social functioning in patients with first episode psychosis

JOURNAL OF PSYCHIATRIC RESEARCH. 2022; 155: 171-179 Nº de citas: 9 [doi:10.1016/j.jpsychires.2022.08.004]

Misra, S; Gelaye, B; Williams, DR; Koenen, KC; Borba, CPC; Quattrone, D; Di Forti, M; Tripoli, G; La Cascia, C; La Barbera, D; Ferraro, L; Tarricone, I; Berardi, D; Lasalvia, A; Tosato, S; Szoke, A; Llorca, PM; Arango, C; Tortelli, A; De Haan, L; Velthorst, E; Bobes, J; Bernardo, M; Sanjuan, J; Santos, JL; Arrojo, M; Del-Ben, CM; Menezes, PR; Selten, JP; Jones, PB; Jongsma, HE; Kirkbride, JB; Rutten, BPF; Van Os, J; Murray, RM; Gayer-Anderson, C; Morgan, C.

Perceived major experiences of discrimination, ethnic group, and risk of psychosis in a six-country case-control study

PSYCHOLOGICAL MEDICINE. 2022; 52(15): 3668-3676 Nº de citas: 12 [doi:10.1017/S0033291721000453]

de Pablo, GS; Moreno, D; Gonzalez-Pinto, A; Paya, B; Castro-Fonieles, J; Baeza, I; Graell, M; Arango, C; Rapado-Castro, M; Moreno, C.

Affective symptom dimensions in early-onset psychosis over time: a principal component factor analysis of the Young Mania Rating Scale and the Hamilton Depression Rating Scale

EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. 2022; 31(11): 1715-1728 Nº de citas: 4 [doi:10.1007/s00787-021-01815-5]

D'Andrea, G; Lal, J; Tosato, S; Gayer-Anderson, C; Jongsma, HE; Stilo, SA; van der Ven, E; Quattrone, D; Velthorst, E; Berardi, D; Menezes, PR; Arango, C; Parellada, M; Lasalvia, A; La Cascia, C; Ferraro, L; La Barbera, D; Sideli, L; Bobes, J; Bernardo, M; Sanjuan, J; Santos, JL; Arrojo, M; Del-Ben, CM; Tripoli, G; Llorca, PM; de Haan, L; Selten, JP; Tortelli, A; Szoke, A; Muratori, R; Rutten, BP; van Os, J; Jones, PB; Kirkbride, JB; Murray, RM; di Forti, M; Tarricone, I; Morgan, C.

Child maltreatment, migration and risk of first-episode psychosis: results from the multinational EU-GEI study

PSYCHOLOGICAL MEDICINE. 2022; 53(13): 1-11 Nº de citas: 8 [doi:10.1017/S003329172200335X]